Defective bone repair in diclofenac treated C57Bl6 mice with and without lipopolysaccharide induced systemic inflammation

Bone repair after trauma or surgical intervention involves a tightly regulated cascade of events that starts with hemostasis and an inflammatory response, which are critical for successful healing. Nonsteroidal anti‐inflammatory drugs (NSAID) are routinely prescribed for pain relief despite their po...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cellular physiology 2019-03, Vol.234 (3), p.3078-3087
Hauptverfasser: Ramirez‐Garcia‐Luna, Jose L., Wong, Timothy H., Chan, Daniel, Al‐Saran, Yazeed, Awlia, Ayman, Abou‐Rjeili, Mira, Ouellet, Suzie, Akoury, Elie, Lemarié, Catherine A., Henderson, Janet E., Martineau, Paul A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Bone repair after trauma or surgical intervention involves a tightly regulated cascade of events that starts with hemostasis and an inflammatory response, which are critical for successful healing. Nonsteroidal anti‐inflammatory drugs (NSAID) are routinely prescribed for pain relief despite their potential inhibitory effect on bone repair. The goal of this study was to determine the impact of administration of the non‐selective NSAID diclofenac in the inflammatory phase of bone repair in mice with or without lipopolysaccharide‐induced systemic inflammation. Repair of femoral window defects was characterized using micro computed tomography imaging and histological analyses at 2 weeks postoperative. The data indicate (a) impaired bone regeneration associated with reduced osteoblast, osteoclast, and macrophage activity; (b) changes in the number, activity, and distribution of mast cells in regenerating bone; and (c) impaired angiogenesis due to a direct toxic effect of diclofenac on vascular endothelial cells. The results of this study provide strong evidence to support the conjecture that administration of NSAIDs in the first 2 weeks after orthopaedic surgery disrupts the healing cascade and exacerbates the negative effects of systemic inflammation on the repair process. Bone repair in mice chronically treated with diclofenac, a nonselective nonsteroidal anti‐inflammatory drug (NSAID), with or without lipopolysaccharides‐induced systemic inflammation was found to be disrupted due to inhibitory effects on osteoblasts, osteoclasts, macrophages, and mast cells, as well as by a direct toxic effect on vascular endothelial cells. The results of this study provide strong evidence to support the conjecture that administration of NSAIDs in the first 2 weeks after orthopaedic surgery disrupts the healing cascade and also appears to exacerbate the negative effects of systemic inflammation on the repair process.
ISSN:0021-9541
1097-4652
DOI:10.1002/jcp.27128